However a meta-analysis of the threeplacebo-controlled trials demonstrated a significant effect of ACE inhibition onthe occurrence of all-cause mortality, cardiovascular mortality, nonfatal MI,stroke, heart failure, and coronary bypass surgery [127]. This evidence concerns the gene ACE and stroke disorder.